Mostrando 7 resultados de: 7
Filtros aplicados
Publisher
Journal of Alzheimer's Disease(3)
Age(1)
Current Pharmaceutical Design(1)
International Journal of Developmental Neuroscience(1)
Neurodegenerative Diseases(1)
Área temáticas
Enfermedades(5)
Fisiología humana(4)
Farmacología y terapéutica(3)
Sistemas fisiológicos específicos de los animales(3)
Ganadería(1)
Origen
scopus(7)
Characterization of amyloid-β granules in the hippocampus of SAMP8 mice
ArticleAbstract: The senescence accelerated mouse-prone 8 (SAMP8) strain of mice is an experimental model of acceleraPalabras claves:Alzheimer's disease, Amyloid-β, hippocampus, HSPG, MAP-2, SAMP8, syndecan, TauAutores:Antoni Camins, Del Valle J., Duran-Vilaregut J., Manich G., Mercader C., Pallás M., Vilaplana J.Fuentes:scopusAntiapoptotic drugs: A therapautic strategy for the prevention of neurodegenerative diseases
ReviewAbstract: The purpose of this review is to discuss potential pathways involved in the pathogenesis of neurodegPalabras claves:Alzheimer's disease, apoptosis, Cyclin-dependent kinases, Glutamate receptors, Neuronal cell death, Neuroprotective drugs. apoptosis, Parkinson's DiseaseAutores:Antoni Camins, Auladell C., Canudas A.M., Folch J., Junyent F., Pallás M., Pelegrí Gabalda C., Sureda F.X., Verdaguer E., Vilaplana J., Zárate C.B.Fuentes:scopusDietary resveratrol prevents Alzheimer's markers and increases life span in SAMP8
ArticleAbstract: Resveratrol is a polyphenol that is mainly found in grapes and red wine and has been reported to bePalabras claves:Alzheimer's disease, AMPK, Memory impairment, Resveratrol, Senescence, Sirtuin 1, Tau, β-AmyloidAutores:Antoni Camins, Bayod S., Canudas A.M., Casadesús G., Del Valle J., Pallás M., Pelegrí Gabalda C., Porquet D., Sanfeliu C., Vicente A., Vilaplana J.Fuentes:scopusCerebral amyloid angiopathy, blood-brain barrier disruption and amyloid accumulation in SAMP8 mice
ArticleAbstract: Cerebrovascular dysfunction and β-amyloid peptide deposition on the walls of cerebral blood vesselsPalabras claves:Alzheimer's disease, Amyloid accumulation, blood-brain barrier, Cerebral amyloid angiopathy, late-onset Alzheimer's disease, SAMP8 miceAutores:Antoni Camins, Del Valle J., Duran-Vilaregut J., Manich G., Pallás M., Pelegrí Gabalda C., Vilaplana J.Fuentes:scopusEarly amyloid accumulation in the hippocampus of SAMP8 mice
ArticleAbstract: Late-onset Alzheimer's disease (AD) is the most common form of AD appearing after 65 years of age. TPalabras claves:aging, Alzheimer's disease, Amyloid-β, Aβ40, Aβ42, AβPP, hippocampus, SAMP8, SAMR1, SenescenceAutores:Antoni Camins, Casadesús G., Del Valle J., Duran-Vilaregut J., Manich G., Pallás M., Pelegrí Gabalda C., Smith M.A., Vilaplana J.Fuentes:scopusMemantine for the treatment of dementia: A review on its current and future applications
ReviewAbstract: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the presence in the brainPalabras claves:Alzheimer's disease, Amyloid-protein, Extrasynaptic N-Methyl-D-aspartate receptor, Memantine, Tau proteinAutores:Antoni Camins, Auladell C., Busquets O., Casadesús G., Castro-Torres R.D., Ettcheto M., Folch J., García M.L., Olloquequi J., Pelegrí Gabalda C., Sanchez-Lopez E., Verdaguer E., Vilaplana J., Zárate C.B.Fuentes:scopusTime-course of blood-brain barrier disruption in senescence-accelerated mouse prone 8 (SAMP8) mice
ArticleAbstract: Senescence of the cerebrovascular system and an abnormal function of the blood-brain barrier have bePalabras claves:Alzheimer's disease, blood-brain barrier, Evans blue, SAMP8, SAMR1Autores:Antoni Camins, Del Valle J., Duran-Vilaregut J., Manich G., Pallás M., Pelegrí Gabalda C., Vilaplana J.Fuentes:scopus